Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 1 analysts
I-Mab's activity chart (see below) currently has 54 price targets and 63 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 34.74% with an average time for these price targets to be met of 100.07 days.
Highest price target for IMAB is $4, Lowest price target is $4.
Most recent stock forecast was given by from BTIG on 24-Oct-2025. First documented stock forecast 11-Feb-2020.
Currently out of the existing stock ratings of IMAB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$9
$5.02 (126.13%)
$9
1 years 3 days ago
(24-Oct-2025)
0/3 (0%)
$4.78 (113.27%)
Buy Since 02-Nov-2021
$6
$2.02 (50.75%)
$5
1 years 1 months 19 days ago
(08-Sep-2025)
3/7 (42.86%)
$1.73 (40.52%)
40
Buy Since 28-Aug-2025
$8
$4.02 (101.01%)
1 years 1 months 29 days ago
(28-Aug-2025)
0/1 (0%)
$3.75 (88.24%)
Buy Since 09-Jul-2025
$7
$3.02 (75.88%)
$7
1 years 2 months 6 days ago
(21-Aug-2025)
1/5 (20%)
$2.29 (48.62%)
85
Buy Since 07-Dec-2020
$7
$3.02 (75.88%)
$7
1 years 2 months 6 days ago
(21-Aug-2025)
2/8 (25%)
$2.29 (48.62%)
59
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst most recently updated their price target on IMAB (I-Mab)?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?